News

Understanding Shareholder Information of Biotalys NV and Its Growth

Understanding Shareholder Information of Biotalys NV and Its Growth

Overview of Biotalys NV's Share Capital and Voting Rights

Biotalys NV, a company headquartered in Ghent, is making significant advancements in the agricultural technology sector. Known for its innovative solutions, Biotalys focuses on biocontrol methods to enhance crop protection during both pre- and post-harvest stages.

Share Capital Breakdown

The share capital of Biotalys NV is established at EUR 5,555,181.05. This figure represents a pivotal component of the company’s financial structure.

Total Voting Securities

As of now, Biotalys has a total of 37,568,645 ordinary shares that possess voting rights. This number underscores the company’s commitment to maintaining shareholder involvement and transparency.

Details of Voting Rights

This number of voting rights reflects the collective power of shareholders to influence company resolutions. Additionally, Biotalys encourages active participation by requiring notifications from any individuals or entities when their voting rights reach or surpass specific thresholds of 5%, 10%, and each multiple of 5% thereafter.

Subscription Rights and Warrants

Biotalys further engages its stakeholders through the issuance of several rights to subscribe for additional securities:

  • 1,779,400 “ESOP Warrants” allow holders to subscribe for 1,779,400 profit certificates, paving the way for eventual conversion into 889,700 voting shares.
  • An additional 1,504,867 “ESOP Warrants” are available, enabling the subscription for the same number of ordinary shares, empowering employees and directors alike.
  • There are 28,653 share units granted as part of the remuneration policy, which includes an obligation for directors to subscribe for new shares at an attractive issue price of one EUR per unit. This strategic move aligns their interests closely with shareholders.

The Absence of Convertible Bonds

It is noteworthy that Biotalys currently holds no outstanding convertible bonds or non-voting shares, indicating a straightforward capital structure that can be advantageous for both the company and its investors.

Innovative Agricultural Solutions

Finding its roots as a spin-off from the Flanders Institute for Biotechnology in 2013, Biotalys continues to expand its portfolio of biocontrol products aimed at pest and disease management across the agricultural value chain. With a strong emphasis on safety and environmental benefits, their AGROBODY™ technology platform positions them as market leaders in the sector.

Market Presence and Future Prospects

As part of the continuous effort to address crucial crop protection needs, Biotalys is actively developing a varied pipeline of product candidates that attract significant attention in both local and international markets. The company’s initiative to balance efficacy with environmental considerations highlights its dedication to sustainable agricultural practices.

This harmonious merge of technology and nature allows Biotalys to offer solutions that not only benefit farmers but also contribute positively to the global ecosystem.

Contact Information

For more insights and inquiries regarding Biotalys NV, please reach out to Toon Musschoot, the Head of Investor Relations and Communication, via telephone at +32 (0)9 274 54 00. Alternatively, you can send an email to IR@biotalys.com.

Frequently Asked Questions

What is Biotalys NV known for?

Biotalys NV specializes in the development of precision biocontrol solutions aimed at enhancing crop protection through environmentally friendly methods.

What is the significance of the share capital?

The share capital illustrates the total financial resources available to the company, reflecting its financial health and investor confidence.

How does Biotalys enhance shareholder engagement?

Through required notifications when voting rights thresholds are crossed, Biotalys ensures that shareholders remain informed and can actively participate in company developments.

What are ESOP Warrants?

ESOP Warrants give holders the right to subscribe to additional shares, which helps align the interests of employees and management with those of shareholders.

What is the AGROBODY™ technology platform?

This innovative technology platform enables Biotalys to create effective biocontrol products, emphasizing both performance and safety in agricultural pest management.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 427

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 401

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
Adding Fireplaces: Home Comfort or Construction Headache?

Updated Category News Views 276

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

Continue Reading
7th World Media Summit Spotlights Media's Future in Beijing

Updated Category News Views 235

The Changing Landscape of Global Media An event of this magnitude doesn't just pop up every day like a stock ticker on Wall Street. This year's 7th World Media Summit in Beijing is where nearly 500 bigwigs from all corners of the media landscape are converging. It's not about trading stocks or hitting quarterly numbers—it's about shaping how stories get told in an era...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 219

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 184

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 347

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 319

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 314

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 365

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading

Top 5 Most Recently Viewed Articles

Affordable Technology Solutions with Human-I-T's Initiative

Updated Category News Views 184

Human-I-T Launches 'Get It Done' Initiative to Bridge Digital Divide Human-I-T has unveiled its new 'Get It Done' Initiative aimed at making essential technology accessible to everyone without straining their finances. This program focuses on providing quality refurbished laptops at an affordable price, ensuring that individuals and families can benefit from reliable...

Continue Reading
Jasper Street Launches Activism Defense Practice with New Partners

Updated Category News Views 125

Jasper Street Partners Strengthens Activism Defense Practice Jasper Street Partners is gearing up to enhance its defense against activist investors by bringing on board two experienced bankers. Their main objective is clear: to assist clients in identifying weaknesses, navigating proxy contests, and managing the pressures that come with public activism. Introducing New...

Continue Reading
Royalty Pharma's $300 Million Partnership with Zenas BioPharma

Updated Category News Views 139

Funding Agreement for Obexelimab Development Royalty Pharma plc and Zenas BioPharma, Inc. have joined forces in a groundbreaking funding agreement that could inject up to $300 million into the development of obexelimab, a promising treatment for autoimmune diseases, specifically IgG4-Related Disease (IgG4-RD). This alliance highlights Royalty Pharma’s commitment to...

Continue Reading
KBR, Inc. Shares Drop Significantly Following Contract News

Updated Category News Views 242

Significant Decline in KBR, Inc. Shares KBR, Inc. (NYSE: KBR) recently faced a substantial decline in its stock value. This shift came after the announcement regarding the termination of a key contract, leaving many investors anxious about the company's future prospects. The market reacted sharply, indicating the level of uncertainty surrounding KBR's operations and...

Continue Reading
Dr. Mike Varshavski to Address Medical Misinformation Soon

Updated Category News Views 407

Dr. Mike Varshavski to Discuss Medical Misinformation The National Press Club is set to host a compelling event featuring Dr. Mikhail "Dr. Mike" Varshavski, a well-known physician and a social media phenomenon. This exciting Headliners event will take place soon, and attendees can expect an engaging dialogue focused on vital issues surrounding medical misinformation and...

Continue Reading